Inventor profile of:

Douglas Hettrick

City:

Andover, Minnesota

Country:

United States

Published Applications:

22

Last publication date:

2025-01-23

Top Assignees for applications by Douglas Hettrick

The entities that hold a legal rights for patent applications filed by inventor Hettrick Douglas:

Recent patent applications by Hettrick Douglas

Douglas Hettrick from Andover, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-01-23
US20250025235A1
Human necessities

METHODS FOR TREATING DEPRESSION IN PATIENTS VIA RENAL NEUROMODULATION

#2 | 2024-12-12
US20240407662A1
Human necessities

SYSTEMS, DEVICES, AND METHODS FOR ASSESSING EFFICACY OF RENAL NEUROMODULATION THERAPY

#3 | 2024-12-05
US20240398252A1
Human necessities

SYSTEMS AND METHODS FOR EVALUATING NEUROMODULATION THERAPY VIA HEMODYNAMIC RESPONSES

#4 | 2023-10-05
US20230309902A1
Human necessities

Systems and methods for assessing sympathetic nervous system tone for renal neuromodulation therapy

#5 | 2023-08-03
US20230240549A1
Human necessities

SYSTEMS AND METHODS FOR ASSESSING EFFICACY OF RENAL NEUROMODULATION THERAPY

#6 | 2022-12-29
US20220409059A1
Human necessities

SYSTEMS AND METHODS FOR MONITORING AND EVALUATING NEUROMODULATION THERAPY

#7 | 2022-08-04
US20220241020A1
Human necessities

METHODS AND SYSTEMS FOR OPTIMIZING PERIVASCULAR NEUROMODULATION THERAPY USING COMPUTATIONAL FLUID DYNAMICS

#8 | 2022-08-04
US20220240807A1
Human necessities

Systems and methods for evaluating neuromodulation therapy via hemodynamic responses

#9 | 2022-05-05
US20220133210A1
Human necessities

Systems, devices, and methods for evaluating neuromodulation therapy via detection of magnetic fields

#10 | 2020-09-10
US20200281476A1
Human necessities

Systems and methods for monitoring and evaluating neuromodulation therapy

#11 | 2020-03-05
US20200069196A1
Human necessities

Systems and methods for assessing efficacy of renal neuromodulation therapy

#12 | 2020-02-06
US20200038102A1
Human necessities

Methods for treating patients with catheter-based renal neuromodulation

#13 | 2019-10-10
US20190307361A1
Human necessities

Systems and methods for evaluating neuromodulation therapy via hemodynamic responses

#14 | 2019-07-25
US20190223956A1
Human necessities

Methods and systems for optimizing perivascular neuromodulation therapy using computational fluid dynamics

#15 | 2019-07-25
US20190223777A1
Human necessities

Systems, devices, and methods for evaluating neuromodulation therapy via detection of magnetic fields

#16 | 2019-07-25
US20190223754A1
Human necessities

Systems, devices, and methods for assessing efficacy of renal neuromodulation therapy

#17 | 2018-08-23
US20180236235A1
Human necessities

Systems, devices, and associated methods for treating patients via renal neuromodulation to reduce a risk of developing cognitive impairment

#18 | 2018-05-03
US20180116723A1
Human necessities

Methods and systems for optimizing perivascular neuromodulation therapy using computational fluid dynamics

#19 | 2017-08-03
US20170215794A1
Human necessities

SYSTEMS AND METHODS FOR MONITORING AND EVALUATING NEUROMODULATION THERAPY

#20 | 2016-11-03
US20160317817A1
Human necessities

Cardiac resynchronization therapy optimization based on intracardiac impedance and heart sounds

#21 | 2015-07-23
US20150202443A1
Human necessities

Cardiac resynchronization therapy optimization based on intracardiac impedance and heart sounds

#22 | 2015-07-23
US20150202436A1
Human necessities

Cardiac resynchronization therapy optimization based on intracardiac impedance

InventorID:

1230787 ⎘